Italy's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 bln deal
Its top-selling drug, Myalept or Myalepta, had third-quarter sales of $37.9 million.
Source: devdiscourse.com
Stay updated with breaking news from Marco Vecchia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Its top-selling drug, Myalept or Myalepta, had third-quarter sales of $37.9 million.
(Reuters) - Italy's Chiesi Farmaceutici said on Sunday it will acquire Ireland-based drugmaker Amryt Pharma Plc, which has products and drugs in devel...